Daikaffil Chemicals India Limited (BOM:530825)
India · Delayed Price · Currency is INR 47.29
-0.96 (-1.99%)
At close: Sep 8, 2026
Daikaffil Chemicals India Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 105 | 133.48 | 74.98 | - | 6.37 | 81.56 | |
Revenue Growth | -7.68% | 78.03% | - | - | -92.19% | -28.47% |
Cost of Revenue | 82.85 | 103.74 | 64.58 | 0.06 | 5.12 | 62.85 |
Gross Profit | 22.16 | 29.74 | 10.4 | -0.06 | 1.25 | 18.72 |
Selling, General & Admin | 17.58 | 17.34 | 11.53 | 16.42 | 12.52 | 24.01 |
Other Operating Expenses | 35.24 | 30.52 | 16.37 | 6.04 | 8.14 | 14.06 |
Operating Expenses | 56.25 | 51.5 | 30.6 | 25.98 | 26.06 | 49.33 |
Operating Income | -34.09 | -21.77 | -20.21 | -26.04 | -24.82 | -30.61 |
Interest Expense | -0.07 | -0.08 | -0.01 | - | -0.01 | -0.33 |
Interest & Investment Income | - | 0.39 | 2.62 | 6.08 | 4.06 | 3.09 |
Currency Exchange Gain (Loss) | - | -1.1 | -0.02 | - | 0.01 | 0.58 |
Other Non Operating Income (Expenses) | 0.52 | - | -0 | - | 0 | -0.01 |
EBT Excluding Unusual Items | -33.65 | -22.56 | -17.62 | -19.96 | -20.75 | -27.28 |
Gain (Loss) on Sale of Assets | - | - | 2.05 | 1.03 | - | - |
Asset Writedown | - | - | -0.46 | - | - | - |
Pretax Income | -33.65 | -22.56 | -16.03 | -18.93 | -20.75 | -27.28 |
Income Tax Expense | -0.47 | -0.42 | -0.13 | 0.09 | 0.59 | -2.25 |
Earnings From Continuing Operations | -33.18 | -22.14 | -15.9 | -19.02 | -21.34 | -25.03 |
Net Income | -33.18 | -22.14 | -15.9 | -19.02 | -21.34 | -25.03 |
Net Income to Common | -33.18 | -22.14 | -15.9 | -19.02 | -21.34 | -25.03 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Change | 0.25% | - | - | - | - | - |
EPS (Basic) | -5.52 | -3.69 | -2.65 | -3.17 | -3.56 | -4.17 |
EPS (Diluted) | -5.52 | -3.69 | -2.65 | -3.17 | -3.56 | -4.17 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 1.8 | -73.85 | 59.18 | -81.47 | -9.66 |
Free Cash Flow Per Share | - | 0.30 | -12.31 | 9.86 | -13.58 | -1.61 |
Gross Margin | 21.10% | 22.28% | 13.87% | - | 19.57% | 22.95% |
Operating Margin | -32.47% | -16.31% | -26.95% | - | -389.51% | -37.53% |
Profit Margin | -31.60% | -16.59% | -21.20% | - | -334.89% | -30.69% |
Free Cash Flow Margin | - | 1.35% | -98.50% | - | -1278.80% | -11.84% |
EBITDA | -31.3 | -18.13 | -17.5 | -22.52 | -19.41 | -22.51 |
EBITDA Margin | -29.81% | -13.58% | -23.34% | - | - | -27.59% |
D&A For EBITDA | 2.8 | 3.64 | 2.71 | 3.52 | 5.41 | 8.1 |
EBIT | -34.09 | -21.77 | -20.21 | -26.04 | -24.82 | -30.61 |
EBIT Margin | -32.47% | -16.31% | -26.95% | - | - | -37.53% |
Revenue as Reported | 105.52 | 134.01 | 79.66 | 7.11 | 10.47 | 86.23 |
Advertising Expenses | - | 0.13 | 0.09 | 0.15 | 0.45 | 0.1 |